Table-4.
Determination of multidrugresistant isolates using in vitro sensitivity.
| Bacterial isolates | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotics (1-15) within antibiotic groups (A-G) | A | 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | RR | ||||||||||
| B | 2 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||||
| 3 | R | R | R | R | R | R | R | RR | R | R | R | R | R | R | R | R | R | R | R | ||||||||||
| 4 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||
| 5 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||
| C | 6 | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||||||||
| D | 7 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||
| E | 8 | R | R | R | R | R | R | R | R | ||||||||||||||||||||
| 9 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||||||
| 10 | R | R | R | R | R | R | R | R | R | R | R | R | R | ||||||||||||||||
| 11 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | |||||||||||||
| F | 12 | R | R | R | R | R | R | ||||||||||||||||||||||
| 13 | R | R | R R | R | R | R | R | R | |||||||||||||||||||||
| 14 | R | R | R | ||||||||||||||||||||||||||
| G | 15 | R | R | R | R | R | R | ||||||||||||||||||||||
(A) Tetracyclines (1-Oxytetracycline), (B) Penicillins (2-ampicillin; 3-amoxycillin; 4-cloxacillin; 5-penicillin), (C) Penicillin/β lactamase inhibitor combination (6-amoxycillin/clavulanic acid), (D) Fluoroquinolones (7-enrofloxacin), (E) Aminoglycosides (8-gentamicin; 9-amikacin; 10-neomycin; 11-streptomycin), (F) Cephalosporins (12-ceftriaxone; 13-cefoperazone; 14-ceftriaxone/tazobactum), (G) Macrolides (15-chloramphenicol). R=Resistant, Blank=Sensitive